# Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis

> **NCT03152487** · NA · COMPLETED · sponsor: **AdventHealth** · enrollment: 28 (actual)

## Conditions studied

- Pancreatic Carcinoma Metastatic
- Pancreatic Adenocarcinoma
- Pancreatic Neoplasms
- Pancreatic Cancer
- Pancreatic Cancer, Adult

## Interventions

- **OTHER:** Celiac Plexus Neurolysis
- **OTHER:** Radiofrequency Ablation

## Key facts

- **NCT ID:** NCT03152487
- **Lead sponsor:** AdventHealth
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152487, "Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03152487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*